期刊文献+

加用西妥昔单抗对顺铂化疗联合调强放疗治疗鼻咽癌的影响 被引量:18

Study on the efficacy of cetuximab in combination with cisplatin chemotherapy and intensity modulated radiotherapy in treatment of patients with nasopharyngeal carcinoma
暂未订购
导出
摘要 目的观察加用西妥昔单抗治疗后对接受顺铂化疗联合调强放疗的鼻咽癌患者的影响。方法选择2010年9月至2013年9月行治疗的鼻咽癌患者45例,随机分为干预组22例和对照组23例。对照组患者给予顺铂化疗联合调强放疗治疗,干预组患者在接受顺铂化疗联合调强放疗的基础上加用西妥昔单抗治疗。观察对比两组患者临床疗效、不良反应发生的情况,比较两组患者间生存质量的差异。结果干预组患者的临床总缓解率高于对照组,两组患者间发生不良反应发生率无显著差异;两组患者间生存质量在接受治疗前与接受治疗中无明显的统计学差异,在接受治疗后,干预组患者的生存质量好于对照组。结论接受顺铂化疗联合调强放疗的鼻咽癌患者在加用西妥昔单抗治疗后可以提高临床治疗效果,改善生存质量,近期效果较好。 Objective To observe the efficacy of cetuximab combined with cisplatin and intensity- modulated radiotherapy in treatment of patients with nasopharygeal carcinoma. Methods A total of 45 patients with nasopharyngeal carcinoma treated in the Department of Radiotherapy in XX hospital,XX city during September 2010 to September 2013 were randomly divided into intervention group( n = 22) and control group( n= 23). Patients in control group were treated with cisplatin chemotherapy combined with intensity- modulated radiation therapy,and patients in intervention group were treated with intensity- modulated radiotherapy on the basis of cisplatin chemotherapy plus cetuximab treatment,and the efficacy,the incidence of adverse reactions and quality of survival of patients were compared between these two groups. Results The clinical remission rate in patients of intervention group was higher than that of patients in control group,and the difference in incidence of adverse reactions was not significant between these two groups,the difference in survival quality of patients before treatment and during the treatment course was not statistically different between these 2 groups,and the quality of living in patients of intervention group after treatment was better than that of patients in control group. Conclusion The application of cisplatin chemotherapy combined with intensity- modulated radiotherapy in addition with cetuximab therapy in treatment of patients with nasopharyngeal carcinoma can significantly improve the therapeutic effectiveness in addition with improvement of the quality of life in these patients with better short- term effect.
出处 《临床和实验医学杂志》 2016年第1期45-48,共4页 Journal of Clinical and Experimental Medicine
关键词 鼻咽癌 西妥昔单抗 顺铂化疗 调强放疗 Nasopharyngeal carcinoma Cetuximab Cisplatin Intensity modulated radiation therapy
  • 相关文献

参考文献12

二级参考文献125

  • 1高剑铭,曾益新,崔念基,卢泰祥,赵充,夏云飞,马骏,谢方云.915例单纯根治性放疗鼻咽癌分期系统比较及建议(一)——对'92福州分期的校验[J].癌症,2005,24(10):1165-1172. 被引量:34
  • 2赵充,卢泰祥,韩非,卢丽霞,黄劭敏,邓小武,林承光,崔念基.139例鼻咽癌调强放疗的临床研究[J].中华放射肿瘤学杂志,2006,15(1):1-6. 被引量:155
  • 3孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生出版社,2008:371.
  • 4Laskin JJ,Sandier AB.Epidermal growth factor receptor:,a promising target in solid tumors[J].Cancer Treat Rev,2004,30(1):1-17.
  • 5Chua DT,Nicholls JM,Sham JS,et al.Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy[J].Int J Radiat Oncol Binl Phys,2004,59(1):11-20.
  • 6Ang KK,Berkey BA,Tu XY,et al.Impact of epidermal growth factor receptor expression on survival and patter of relapse in patients with advanced head and neck carcinoma[J].Cancer Res,2002,62(24):7350-6.
  • 7Chan AT,Hsu MM,Goh BC,et al.Mulficenter,phase Ⅱ study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma[J].J Clin Oncol,2005,23(15):3568-76.
  • 8Ciardiello F,Bianco R,Damiano V,et al.Antiangiogenic and antitumor activity of antiepidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonuclcotide in human GEO colon cancer cells[J].Clin Cancer Res,2000,6(9):3739-47.
  • 9Viloria-Petit A,Crombet T,Jothy S,et al.Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo:a role for altered tumor angiogenesis[J].Cancer Res,2001,61(13):5090-101.
  • 10Kersemaekers Am,van de Vijver MJ,Kenter GG,et al.Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix[J].Genes Chromosomes Cancer,1999,26(4):346-54.

共引文献96

同被引文献172

引证文献18

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部